CN

Product Overview

Bionic Cough Stimulator help the patients with invasive mechanical ventilation clear the secretions from the airway by simulating the mechanism of normal physiological cough. This product has patented technology for invention (invention patent number ZL201580000283.2). BCS3 can effectively expel sputum while ensuring normal ventilation without disconnecting the ventilator. Simulating the physiological cough mechanism avoids the damage to the airway caused by the current routine sputum excretion process.

Characteristics and Advantages

  • Parallel operation: work together with the ventilator by simulating physiological cough; maintain PEEP and thus protect patients from alveolar collapse and atelectasis
  • Closed non-invasive suction with negative air pressure: secretion suction from deep bronchi; avoid tracheal injury, pulmonary contamination and ultimately VAP
  • Patient compliance: make the whole treatment more comfortable for patients
  • Medical works friendly: lower risk of infection; BCS3 in automatic mode reduces workload for medical workers

Application Scope

  • SICU (Surgical Intensive Care Unit)

  • RICU (Respiratory Intensive Care Unit)

  • MICU (Medical Intensive Care Unit)

  • CICU (Cardiovascular Intensive Care Unit)

  • EICU (Emergency Intensive Care Unit)

  • NICU (Neurological Intensive Care Unit)

  • AICU (Anesthesiology Intensive Care Unit)

  • BICU (Burn Intensive Care Unit)

info@yaguor.com   
010-53517151/010-61258012/400-700-5078
Room317, Building 6, ZhongGuanCun Advanced Medical Device Park, NO.26, West Yongwang Road, Daxing District, Beijing
Copyright © 2020 北京雅果科技有限公司 版权所有京ICP备15016733号-1
药品医疗器械网络信息服务备案(非经营性)[(京)网药械信息备字(2023)第 00508 号]
Design by Wanhu.